Multifactorial experimental design approach in forced degradation studies with a focus on the intensity of stress conditions – A trastuzumab case study

Read full text
Authors: Klaus Kronsbein, Lukas Schmuck, Verena Nold, Armin Böhrer, Beate Presser, Ingo Hinz, Matthias Knape, Katharina Schindowski, Boris Mizaikoff, Florian Krattenmacher
Cited by: 1
References: 66

Abstract

A robust understanding of structure-function relationships (SFRs) is fundamental for tailored and robust chemistry, manufacturing, and control (CMC) activities. Yet, conventional forced degradation studies (FDS) often employ a one-factor-at-a-time (OFAT) methodology, which commonly leads to correlated modifications and therefore limited reliability of SFR determination missing statistical certainty. By applying a forced-degradation-study design of experiments (FDS-DoE) framework to trastuzumab, methodological advantages are underscored, including improved data interpretation and consistency with literature findings, while adding deeper insights to the antibodies SFRs. As the choice of stress conditions in the design of FDS studies is critically important to establish meaningful SFRs, we present a detailed experimental comparison of harsh vs. moderate CMC development relevant stress conditions applying the FDS-DoE workflow. While harsh conditions mainly reflect typical FDS protocols and test the boundaries of a molecule's resilience, the moderate conditions were designed to simulate CMC-relevant environments better. Furthermore, we introduce a critical quality attribute (CQA) assessment framework that uses partial least square regression to systematically categorize modifications according to their statistical significance (via permutation testing) and predicted potency loss. The combination of multifactorial FDS-DoE with this CQA assessment framework increased statistical power over traditional OFAT methods, establishing a predictive, automated and scalable strategy for identifying relevant SFRs and CQAs, a capability especially advantageous for macromolecules in biopharmaceutical development.

Fields of Study & Subjects

Protein purification and stability Viral Infectious Diseases and Gene Expression in Insects Monoclonal and Polyclonal Antibodies Research

Publication details

Journal / source
International Journal of Biological Macromolecules
Publisher
Elsevier BV
Volume
370
Pages
152614–152614
Publication date
19 May 2026
Language
EN